CRVS insider trading

Open-market stock trades by Corvus Pharmaceuticals (CRVS) executives and directors: who bought or sold, how many shares, at what price and when.

CRVS insider trades

DateInsiderRoleTradeSharesPriceValue
Jun 11, 2026Moore David ScottdirectorBuy21,700$11.53$250.24K
May 18, 2026MILLER RICHARD A MDPresident and CEOBuy1,932$12.01$23.20K
May 18, 2026MILLER RICHARD A MDPresident and CEOBuy5,000$12.05$60.25K
Jun 27, 2025ORBIMED ADVISORS LLCSell1,176,332$4.16$4.89M
Jun 27, 2025Thompson Peter A.Sell1,176,332$4.16$4.89M
May 6, 2024Thompson Peter A.Buy1,444,085$0.00$144.41
May 6, 2024Thompson Peter A.Buy1,397,684$3.50$4.89M
May 6, 2024ORBIMED ADVISORS LLCBuy1,444,085$0.00$144.41
May 6, 2024ORBIMED ADVISORS LLCBuy1,397,684$3.50$4.89M
May 6, 2024Jones William BentonSee RemarksBuy20,000$1.73$34.62K
May 6, 2024Jones William BentonSee RemarksBuy19,357$3.50$67.75K
May 6, 2024MILLER RICHARD A MDPresident and CEOBuy577,634$1.73$1000.00K
May 6, 2024MILLER RICHARD A MDPresident and CEOBuy559,073$3.50$1.96M
May 15, 2023Grais LindadirectorBuy10,000$2.45$24.50K
Dec 20, 2022Jones William BentonSee RemarksBuy20,000$0.79$15.80K
Dec 14, 2022LEA LEIVChief Financial OfficerBuy4,000$0.84$3.36K
Dec 13, 2022LEA LEIVChief Financial OfficerBuy30,000$0.74$22.27K
Dec 14, 2022MILLER RICHARD A MDPresident and CEOBuy10,000$0.78$7.81K
Dec 13, 2022MILLER RICHARD A MDPresident and CEOBuy50,000$0.74$37.02K

Updated 2026-11-05 12:51 UTC